Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Q Chen

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Infectious Diseases|November 5, 2016
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
The Journal of Infectious Diseases|October 13, 2011
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
Annals of Internal Medicine|August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized TrialRoy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2018
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052Philip J Palumbo, Jessica M Fogel, Sarah E Hudelson, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 18, 2016
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2016
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 TrialJessica M Fogel, Sarah E Hudelson, San-San Ou, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Infectious Diseases|November 5, 2016
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
The Journal of Infectious Diseases|October 13, 2011
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
Annals of Internal Medicine|August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized TrialRoy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2018
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052Philip J Palumbo, Jessica M Fogel, Sarah E Hudelson, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 18, 2016
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2016
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 TrialJessica M Fogel, Sarah E Hudelson, San-San Ou, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
Pageof 4